- Home
- NPKI vs PHAR Comparison
NPKI vs PHAR Comparison
Compare NPKI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- PHAR
- Stock Information
- Founded
- NPKI 1932
- PHAR 1988
- Country
- NPKI United States
- PHAR Netherlands
- Employees
- NPKI N/A
- PHAR N/A
- Industry
- NPKI Metal Fabrications
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- PHAR Health Care
- Exchange
- NPKI Nasdaq
- PHAR Nasdaq
- Market Cap
- NPKI 665.2M
- PHAR 679.0M
- IPO Year
- NPKI N/A
- PHAR N/A
- Fundamental
- Price
- NPKI $7.70
- PHAR $9.98
- Analyst Decision
- NPKI
- PHAR Strong Buy
- Analyst Count
- NPKI 0
- PHAR 3
- Target Price
- NPKI N/A
- PHAR $27.00
- AVG Volume (30 Days)
- NPKI 484.1K
- PHAR 5.9K
- Earning Date
- NPKI 02-19-2025
- PHAR 03-13-2025
- Dividend Yield
- NPKI N/A
- PHAR N/A
- EPS Growth
- NPKI N/A
- PHAR N/A
- EPS
- NPKI N/A
- PHAR N/A
- Revenue
- NPKI $748,372,000.00
- PHAR $285,745,000.00
- Revenue This Year
- NPKI N/A
- PHAR $20.08
- Revenue Next Year
- NPKI N/A
- PHAR $9.22
- P/E Ratio
- NPKI $19.86
- PHAR N/A
- Revenue Growth
- NPKI 93.70
- PHAR 30.64
- 52 Week Low
- NPKI $5.61
- PHAR $6.65
- 52 Week High
- NPKI $8.65
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- PHAR 56.13
- Support Level
- NPKI N/A
- PHAR $9.37
- Resistance Level
- NPKI N/A
- PHAR $10.15
- Average True Range (ATR)
- NPKI 0.00
- PHAR 0.50
- MACD
- NPKI 0.00
- PHAR -0.09
- Stochastic Oscillator
- NPKI 0.00
- PHAR 57.53
About NPKI NPK International Inc. Common Stock
NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.